| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 化学药品(元) | 771,486,007.92 | 351,951,250.86 | 693,543,937.97 | 389,914,783.68 |
| 生物药品(元) | 519,722,774.38 | 212,097,244.84 | 526,508,791.83 | 201,107,157.54 |
| 营业成本(元) | ||||
| 化学药品(元) | 146,369,169.27 | 65,733,575.29 | 157,936,176.02 | 76,427,414.10 |
| 生物药品(元) | 72,640,034.03 | 25,154,532.02 | 62,952,957.27 | 23,762,500.72 |
| 毛利(元) | ||||
| 化学药品(元) | 625,116,838.65 | 286,217,675.57 | 535,607,761.95 | 313,487,369.58 |
| 生物药品(元) | 447,082,740.35 | 186,942,712.82 | 463,555,834.56 | 177,344,656.82 |
| 毛利率(%) | ||||
| 化学药品(%) | 81.03 | 81.32 | 77.23 | 80.40 |
| 生物药品(%) | 86.02 | 88.14 | 88.04 | 88.18 |
| 收入构成(%) | ||||
| 化学药品(%) | 59.75 | 62.40 | 56.85 | 65.97 |
| 生物药品(%) | 40.25 | 37.60 | 43.15 | 34.03 |
| 毛利构成(%) | ||||
| 化学药品(%) | 58.30 | 60.49 | 53.61 | 63.87 |
| 生物药品(%) | 41.70 | 39.51 | 46.39 | 36.13 |